ZA751007B - Oral pharmaceutical preparation - Google Patents

Oral pharmaceutical preparation

Info

Publication number
ZA751007B
ZA751007B ZA00751007A ZA751007A ZA751007B ZA 751007 B ZA751007 B ZA 751007B ZA 00751007 A ZA00751007 A ZA 00751007A ZA 751007 A ZA751007 A ZA 751007A ZA 751007 B ZA751007 B ZA 751007B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical preparation
oral pharmaceutical
oral
preparation
pharmaceutical
Prior art date
Application number
ZA00751007A
Other languages
English (en)
Inventor
Vies J Van Der
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of ZA751007B publication Critical patent/ZA751007B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
ZA00751007A 1974-02-28 1975-02-18 Oral pharmaceutical preparation ZA751007B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NLAANVRAGE7402689,A NL189235C (nl) 1974-02-28 1974-02-28 Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking.

Publications (1)

Publication Number Publication Date
ZA751007B true ZA751007B (en) 1976-01-28

Family

ID=19820854

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00751007A ZA751007B (en) 1974-02-28 1975-02-18 Oral pharmaceutical preparation

Country Status (11)

Country Link
US (1) US4220599A (nl)
BE (1) BE826086A (nl)
CA (1) CA1038760A (nl)
DE (1) DE2508615A1 (nl)
FR (1) FR2262527B1 (nl)
GB (1) GB1500374A (nl)
HU (1) HU173417B (nl)
IE (1) IE40681B1 (nl)
NL (1) NL189235C (nl)
PH (1) PH13807A (nl)
ZA (1) ZA751007B (nl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7506407A (nl) * 1975-05-30 1976-12-02 Akzo Nv Werkwijze ter bereiding van een oraal werkzaam far- maceutisch preparaat.
NL7510104A (nl) * 1975-08-27 1977-03-01 Akzo Nv Werkwijze ter bereiding van een oraal werkzaam farmaceutisch preparaat.
GB1567515A (en) * 1976-05-28 1980-05-14 Akzo Nv Esters of testo-sterone and 5 -dihydro-testosterone
NL7613248A (nl) * 1976-11-26 1978-05-30 Akzo Nv Werkwijze voor het bereiden van nieuwe steroid- esters.
AT358530B (de) * 1978-04-25 1980-09-10 Plc Pharma Licences Stabilisierungsverfahren
DE19619045C1 (de) * 1996-05-02 1997-11-13 Jenapharm Gmbh Verwendung von Kombinationspräparaten zur Behandlung hypogonadaler Männer sowie Männern mit Hypophysenerkrankungen
US6139873A (en) * 1996-07-10 2000-10-31 Cedars-Sinai Medical Center Combined pharmaceutical estrogen-androgen-progestin
US5770226A (en) * 1996-07-10 1998-06-23 Wake Forest University Combined pharmaceutical estrogen-androgen-progestin oral contraceptive
US6652880B1 (en) 1999-04-01 2003-11-25 R.P. Scherer Technologies, Inc. Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants
AU777770C (en) 1999-05-04 2005-11-10 Strakan International Limited Androgen glycosides and androgenic activity thereof
ATE311201T1 (de) * 2000-08-23 2005-12-15 Akzo Nobel Nv Testosteron-ester formulierung zur anwendung am menschen
FR2834897B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de testosterone
US20050287203A1 (en) * 2002-05-08 2005-12-29 Nijs De H Formulation comprising testosteron undecanoate and castor oil
RU2429850C2 (ru) 2005-04-15 2011-09-27 Кларус Терапьютикс, Инк. Фармацевтические системы доставки для гидрофобных лекарственных средств и композиций, их содержащих
US8492369B2 (en) 2010-04-12 2013-07-23 Clarus Therapeutics Inc Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9034858B2 (en) * 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) * 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
TW201521731A (zh) * 2013-03-15 2015-06-16 利波辛股份有限公司 用於口服之脂平衡的長鏈睪固酮酯
ES2749008T3 (es) 2014-06-17 2020-03-18 Merck Sharp & Dohme Formulaciones estables de undecanoato de testosterona
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
JP2020503269A (ja) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド 経口ウンデカン酸テストステロン療法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2855341A (en) * 1954-07-02 1958-10-07 Ciba Pharm Prod Inc Testosterone compositions
US3714353A (en) * 1959-08-11 1973-01-30 Upjohn Co THERAPEUTIC COMPOSITIONS COMPRISING A 6 alpha ; 9 alpha -DIFLUORO-11 beta ,17 alpha ,21-TRIHYDROXY-16 alpha -METHYL-1,4-PREGNADIENE-3,20-DIONE AND 21-ACYLATES
US3374230A (en) * 1966-04-26 1968-03-19 Schering Corp Acetylation of steroidal alcohols with ketene
CH502325A (de) * 1966-12-09 1971-01-31 Ciba Geigy Ag Verfahren zur Herstellung von Aldehyden der Pregnanreihe und ihrer Derivate
US4147783A (en) * 1974-02-28 1979-04-03 Akzona Incorporated Oral pharmaceutical preparation

Also Published As

Publication number Publication date
FR2262527B1 (nl) 1978-08-04
BE826086A (fr) 1975-08-27
CA1038760A (en) 1978-09-19
DE2508615C2 (nl) 1989-10-12
US4220599A (en) 1980-09-02
FR2262527A1 (nl) 1975-09-26
NL7402689A (nl) 1975-09-01
HU173417B (hu) 1979-05-28
NL189235C (nl) 1993-02-16
AU7838675A (en) 1976-08-26
IE40681B1 (en) 1979-08-01
NL189235B (nl) 1992-09-16
PH13807A (en) 1980-10-01
DE2508615A1 (de) 1975-09-04
IE40681L (en) 1975-08-28
GB1500374A (en) 1978-02-08

Similar Documents

Publication Publication Date Title
ZA751007B (en) Oral pharmaceutical preparation
ZA751806B (en) Pharmaceutical compositions
ZA741963B (en) Oral drug preparations
ZA762920B (en) Novel pharmaceutical preparation adapted for oral administration
ZA764868B (en) Novel pharmaceutical preparation adapted for oral administration
ZA74385B (en) Pharmaceutical compositions
ZA751102B (en) Pharmaceutical preparations
ZA755998B (en) Pharmaceutical compositions
IL48508A (en) Pharmaceutical compositions comprising piperidylindole derivatives
HK17281A (en) Pharmaceutical compositions
NZ179502A (en) Ii-desoxy-omega-tetra norprostaglanding internediates pharmaceutical composition
HK70580A (en) New pharmaceutical compositions and a process for the preparation thereof
ZA755802B (en) Pharmaceutical compositions
AU8487175A (en) Pharmaceutical preparations
MY7900033A (en) Pharmaceutical compositions
PH12855A (en) Pharmaceutical compositions
GB1367608A (en) Oral pharmaceutical dosage form
ZA745332B (en) Oral preparations
ZA753130B (en) New pharmaceutical compounds
ZA755515B (en) Pharmaceutical formulations
AU7569174A (en) Pharmaceutical preparations
AU493419B2 (en) Oral pharmaceutical preparation
CS180187B1 (en) Pharmaceutical preparation
ZA757295B (en) Hypolipemising drug
IE39585B1 (en) Pharmaceutical compostitions